rs202169962
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_014855.3(AP5Z1):āc.490A>Gā(p.Ser164Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000253 in 1,612,644 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_014855.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP5Z1 | NM_014855.3 | c.490A>G | p.Ser164Gly | missense_variant | 4/17 | ENST00000649063.2 | NP_055670.1 | |
AP5Z1 | NM_001364858.1 | c.22A>G | p.Ser8Gly | missense_variant | 3/16 | NP_001351787.1 | ||
AP5Z1 | XM_047421098.1 | c.154A>G | p.Ser52Gly | missense_variant | 2/15 | XP_047277054.1 | ||
AP5Z1 | NR_157345.1 | n.583A>G | non_coding_transcript_exon_variant | 4/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP5Z1 | ENST00000649063.2 | c.490A>G | p.Ser164Gly | missense_variant | 4/17 | NM_014855.3 | ENSP00000497815.1 |
Frequencies
GnomAD3 genomes AF: 0.000382 AC: 58AN: 152022Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000887 AC: 220AN: 248066Hom.: 3 AF XY: 0.000741 AC XY: 100AN XY: 134864
GnomAD4 exome AF: 0.000240 AC: 350AN: 1460504Hom.: 5 Cov.: 32 AF XY: 0.000211 AC XY: 153AN XY: 726558
GnomAD4 genome AF: 0.000381 AC: 58AN: 152140Hom.: 1 Cov.: 33 AF XY: 0.000390 AC XY: 29AN XY: 74372
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 48 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 03, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at